Literature DB >> 29769928

Gonorrhea in Canada: 2003-2012.

S Totten1, R MacLean1, E Payne1.   

Abstract

BACKGROUND: Gonorrhea is the second most commonly reported sexually transmitted infection in Canada. Between 1991 and 1997, Canada experienced a sharp decline in the rates of reported cases of gonorrhea, followed by a steady incline.
OBJECTIVE: To identify trends in reported cases of gonorrhea in Canada from January 1, 2003 to December 31, 2012.
METHODS: Notifiable disease reports were submitted to the Public Health Agency of Canada by provincial and territorial epidemiological units and data were summarized by age and sex.
RESULTS: Between 2003 and 2012, the rate of reported cases of gonorrhea increased by 38.9%, from 26.0 to 36.2 per 100,000. Over this time frame, a greater relative rate increase was observed in females, though rates of gonorrhea increased in both sexes and across all age groups. In 2012, as in previous years, the rate of reported cases of gonorrhea was higher in males than females (41.4 vs. 31.0 per 100,000). Females between the ages of 15 and 24 years and males between the ages of 20 and 29 years accounted for the highest rates of gonorrhea in 2012.
CONCLUSION: In Canada, as in many countries, gonorrhea is on the rise, especially in young adults. This increase in rates of reported cases is in part due to improved diagnosis through nucleic acid amplification (NAAT) testing and may also be affected by growing gonococcal resistance to many available treatments.

Entities:  

Year:  2015        PMID: 29769928      PMCID: PMC5864307          DOI: 10.14745/ccdr.v41i02a02

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  5 in total

1.  Epidemiology of chlamydial infection: are we losing ground?

Authors:  M L Rekart; R C Brunham
Journal:  Sex Transm Infect       Date:  2008-01-23       Impact factor: 3.519

2.  Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-08-10       Impact factor: 17.586

Review 3.  From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection.

Authors:  D T Fleming; J N Wasserheit
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

4.  Antimicrobial resistance in gonorrhea: the influence of epidemiologic and laboratory surveillance data on treatment guidelines: Alberta, Canada 2001-2007.

Authors:  Sabrina Plitt; Curtiss Boyington; Karen Sutherland; Marguerite Lovgren; Peter Tilley; Ron Read; Ameeta E Singh
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

5.  Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009-2013.

Authors:  I Martin; P Sawatzky; G Liu; M R Mulvey
Journal:  Can Commun Dis Rep       Date:  2015-02-05
  5 in total
  3 in total

1.  Interventions for preventing ophthalmia neonatorum.

Authors:  Vimal Scott Kapoor; Jennifer R Evans; S Swaroop Vedula
Journal:  Cochrane Database Syst Rev       Date:  2020-09-21

2.  What are Canadian primary care physicians prescribing for the treatment of gonorrhea?

Authors:  S Ha; L Pogany; J Seto; J Wu; M Gale-Rowe
Journal:  Can Commun Dis Rep       Date:  2017-02-02

3.  Gonorrhea in Canada, 2010-2015.

Authors:  Y Choudhri; J Miller; J Sandhu; A Leon; J Aho
Journal:  Can Commun Dis Rep       Date:  2018-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.